The novel immunobiotic Clostridium butyricum S-45-5 displays broad-spectrum antiviral activity in vitro and in vivo by inducing immune modulation.

Front Immunol · 2023 · PMC10595006 · PMID 37881429

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In all experiments, *p<0.05, **p<0.01, and ***p<0.001 were regarded as differentially significant, significant, and highly significant, respectively.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

The novel immunobiotic <i>Clostridium butyricum</i> S-45-5 displays broad-spectrum antiviral activity <i>in vitro</i> and <i>in vivo</i> by inducing immune modulation.

The sentences